Treatment of Intra-Oral Ranula with Picibanil(R) in Children.
- Author:
Jeong Su WOO
1
;
Myung Ho JUNG
;
Il Ho PARK
;
Seung Won CHUNG
;
Soon Jae HWANG
;
Heung Man LEE
Author Information
1. Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Korea.
- Publication Type:Clinical Trial ; Original Article
- Keywords:
Ranula;
Picibanil
- MeSH:
Child*;
Female;
Fever;
Humans;
Injections, Intralesional;
Picibanil;
Prospective Studies;
Ranula*;
Recurrence;
Sclerotherapy
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2004;47(7):665-668
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Although surgical excision has been considered to be the treatment of choice by most of the surgeons, sclerotherapy of ranula has gained popularity during recent years. A prospective clinical trial was conducted to evaluate the efficacy of Picibanil(R) sclerotherapies for treating ranula children. SUBJECTS AND METHOD: Three patients were enrolled in the study conducted during 2002. All patients were not hospitalized. Picibanil(R) was injected into the lesion. One girl and two boys with ages ranging from 8 to 12 years were treated. RESULTS: Disappearance or marked reduction of the lesion and no recurrence of the ranula were observed in all children. Following each injection, local pain at the injection site was observed in 2 children and transient fever was observed in one child, but such problems resolved within a few days and no serious complication was developed. CONCLUSION: Our experience gives a suggestion that intralesional injection therapy using Picibanil(R) for intraoral ranula is relatively safe and can be used as a substitute for surgery in the treatment of ranula.
